THERAPEUTIC SELECTIVITY OF AND PREDICTION OF RESPONSE TO 2'-DEOXYCOFORMYCIN IN ACUTE LEUKAEMIA
- 1 December 1981
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 318 (8258), 1250-1254
- https://doi.org/10.1016/s0140-6736(81)91491-4
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Studies on the Biochemical Sequelae of Therapy in Thy-Acute Lymphoblastic Leukaemia with the Adenosine Deaminase Inhibitor 2’DeoxycoformycinBritish Journal of Haematology, 1981
- Prognostic Importance of Immunologic Markers in Adult Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1981
- REMISSION INDUCTION WITH ADENOSINE-DEAMINASE INHIBITOR 2'-DEOXYCOFORMYCIN IN THY-LYMPHOBLASTIC LEUKÆMIAThe Lancet, 1980
- CYCLOSPORIN A TO PREVENT GRAFT-VERSUS-HOST DISEASE IN MAN AFTER ALLOGENEIC BONE-MARROW TRANSPLANTATIONThe Lancet, 1980
- Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First RemissionNew England Journal of Medicine, 1979
- Adenosine deaminase activity in chronic lymphocytic leukemia. Relationship to B- and T-cell subpopulations.JCI Insight, 1976
- SUCCESSFUL FETAL LIVER TRANSPLANTATION IN A CHILD WITH SEVERE COMBINED IMMUNODEFICIENCYThe Lancet, 1975
- Combined immunodeficiency disease associated with adenosine deaminase deficiency: Report on a Workshop Held in Albany, New York, October 1, 1973The Journal of Pediatrics, 1975
- A novel adenosine and ara‐a deaminase inhibitor, (R)‐3‐(2‐deoxy‐β‐D‐erythro‐pentofuranosyl)‐3,6,7,8‐tetrahydroimidazo[4,5 ‐d] [1,3]diazepin‐8‐olJournal of Heterocyclic Chemistry, 1974
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972